Skip to Main Content
  • Members
  • Client Resources
  • Pharmacy + Provider Resources
  • Drug Recalls
  • Events
Prime Therapeutics logo
  • Who we are
    • About us

      Discover our purpose and how we’re transforming health care.

    • Corporate social responsibility

      Learn how we're fostering a culture of care and shared purpose.

  • Our solutions
    • Solutions overview

      Explore our innovative solutions for better health care.

    • Modern technology

      See how we’re shaping the future of health care.

    • Drug access

      Deliver access and affordability while promoting adherence.

    • Clinical solutions

      Improve member outcomes with expert clinical solutions.

    • Condition management

      Help members manage chronic health conditions.

    • Specialty drug management

      Get support managing high-cost specialty drugs.

    • Government solutions

      Access trusted pharmacy solutions from the government experts.

    • Single-state programs

      Streamline Medicaid drug management.

  • Read, watch, listen
    • Read

      Explore insights and articles from our pharmacy experts.

    • Watch

      See how we are reimagining pharmacy solutions.

    • Listen

      Tune in to podcasts for strategies on the future of pharmacy.

  • Pharmacy
    • Home Delivery

      Manage home delivery prescriptions.

    • Specialty Pharmacy

      Get personalized support for complex specialty meds.

  • Careers
  • Home
    • Who we are
      • About us
        • Employers
        • Health Plans
        • Consultants
        • Union
      • Our history
      • Culture
        • Diversity, equity and inclusion
          • Diverse supplier registration
      • Corporate social responsibility
        • Community giving
        • Climate reporting
        • Corporate Social Responsibility Report
        • Prime Together Foundation
      • Awards
    • Read, watch, listen
      • Read
      • Watch
      • Listen
    • Pharmacy
      • Home Delivery
        • Home Delivery - Patients
        • Home Delivery - Providers
      • Specialty Pharmacy
        • Specialty Pharmacy - Patients
          • Care Specialists Program
            • Education Center
              • Hypercholesterolemia
              • Solid organ transplant
              • Asthma
              • Cystic fibrosis
              • Hemophilia
              • Hepatitis C
              • Human Immunodeficiency Virus (HIV)
              • Inflammatory bowel disease
              • Osteoporosis
              • Multiple Sclerosis
              • Oncology (cancer)
              • Psoriasis and psoriatic arthritis
              • Rheumatoid arthritis
            • Rights and responsibilities
            • Overcome medicine challenges
        • Specialty Pharmacy - Providers
      • Patient Forms
    • Careers
      • Benefits
      • Hub + Home
      • Medication Therapy Management Internship
      • Managed Care Residency Program
      • Application Process
    • Contact Us
  • News & Insights
    • Events
    • In the news
    • Perspectives
    • Press releases
    • Research & publications
      • Cell & Gene Pipeline Outlook
        • 2024-2025
          • Cell & Gene Pipeline Outlook: November 2025
        • Cell & Gene Pipeline Outlook: January 2026
        • Cell & Gene Pipeline Outlook: June 2026
      • Clinical Insights
        • 2022 Clinical Insights: Therapeutic Psychedlics: An emerging frontier in mental health
        • 2022 Clinical Insights: Virtual reality: An emerging paradigm in healthcare
        • Summer 2025 Issue: Clinical Insights – MASH
      • Drug Approvals
        • Drug Approvals Monthly Update: January 2024
        • Drug Approvals Quarterly Update: January 2024
        • Drug Approvals Monthly Update: February 2024
        • Drug Approvals Monthly Update: April 2024
        • Drug Approvals Quarterly Update: April 2024
        • Drug Approvals Monthly Update: March 2024
        • Drug Approvals Monthly Update: May 2024
        • Drug Approvals Monthly Update: June 2024
        • Drug Approvals: July 2024
        • Drug Approvals Monthly Update: August 2024
        • Drug Approvals Monthly Update: September 2024
        • Drug Approvals: October 2024
        • Drug Approvals: November 2024
        • Drug Approvals: December 2024
        • Drug Approvals: January 2025
        • Drug Approvals: February 2025
        • Drug Approvals: March 2025
        • Drug Approvals: April 2025
      • FDA Decisions Expected
        • 2024-2025
          • FDA Decisions Expected: October 2024
          • FDA Decisions Expected November 2024
          • FDA Decisions Expected: December 2024
          • FDA Decisions Expected: January 2025
          • FDA Decisions Expected: February 2025
          • FDA Decisions Expected: March 2025
          • FDA Decisions Expected: April 2025
          • FDA Decisions Expected: May 2025
          • FDA Decisions Expected: June 2025
          • FDA Decisions Expected: July 2025
          • FDA Decisions Expected: August 2025
          • FDA Decisions Expected: September2025
          • FDA Decisions Expected: October 2025
          • FDA Decisions Expected: November 2025
          • FDA Decisions Expected: December 2025
        • FDA Decisions Expected: January 2026
        • FDA Decisions Expected: February 2026
        • FDA Decisions Expected: March 2026
        • FDA Decisions Expected: April 2026
        • FDA Decisions Expected: May 2026
        • FDA Decisions Expected: June 2026
        • FDA Decisions Expected: July 2026
        • FDA Decisions Expected: August 2026
        • FDA Decisions Expected: September 2026
        • FDA Decisions Expected: October 2026
      • GLP-1 Pipeline Update
        • 2024-2025
          • GLP-1 Pipeline Update: November 2024
          • GLP-1 Pipeline Update: November 2025
          • The evolution of GLP-1s
          • GLP-1 Pipeline Update: February 2025
          • GLP-1 Pipeline Update: May 2025
          • GLP-1 Pipeline Update: August 2025
        • GLP-1 Pipeline Update: February 2026
        • GLP-1 Pipeline Update: May 2026
        • GLP-1 Pipeline Update: August 2026
      • Medicaid Trend Report
      • Medical Pharmacy Trend Report
        • 2024 Medical Pharmacy Trend Report
        • 2025 Medical Pharmacy Trend Report
        • 2026 Medical Pharmacy Trend Report Part 1
        • 2026 Medical Pharmacy Trend Report Part 2
      • Oncology Insights
        • 2024-2025
          • Oncology Insights: Transformative treatment for small cell lung cancer
          • Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage
          • Oncology Insights: October 2024
          • Oncology Insights: December 2024
          • Oncology Insights: 2024 Rewind
          • Oncology Insights: February 2025
          • Oncology Insights: March 2025
          • Oncology Insights: April 2025
          • Oncology Insights: May 2025
          • Oncology Insights: June 2025
          • Oncology Insights: July 2025
          • Oncology Insights: August 2025
          • Oncology Insights: September 2025
          • Oncology Insights: October 2025
          • Oncology Insights: November 2025
          • Oncology Insights: December 2025
        • Oncology Insights: January 2026
        • Oncology Insights: February 2026
        • Oncology Insights: March 2026
        • Oncology Insights: April 2026
        • Oncology Insights: May 2026
        • Oncology Insights: June 2026
        • Oncology Insights: July 2026
        • Oncology Insights: August 2026
      • Prime Therapeutics Report
        • Fall 2024 Prime Therapeutics Report
        • Spring 2024 Prime Therapeutics Report
        • Summer 2024 Prime Therapeutics Report
        • Spring 2025 Prime Therapeutics Report
        • Summer 2025 Prime Therapeutics Report
        • Fall 2025 Prime Therapeutics Report
        • Spring 2026 Prime Therapeutics Report
        • Summer 2026 Prime Therapeutics Report
      • Quarterly Drug Pipeline
        • 2024-2025
          • Quarterly Drug Pipeline Template 2.0
          • Quarterly Drug Pipeline: January 2024
          • Quarterly Drug Pipeline: April 2024
          • Quarterly Drug Pipeline: July 2024
          • Quarterly Drug Pipeline: October 2024
          • Quarterly Drug Pipeline: January 2025
          • Quarterly Drug Pipeline: April 2025
          • Quarterly Drug Pipeline: July 2025
          • Quarterly Drug Pipeline: October 2025
        • Quarterly Drug Pipeline: January 2026
        • Quarterly Drug Pipeline: April 2026
        • Quarterly Drug Pipeline: July 2026
      • Research posters & abstracts
      • Trending Topics & Drug Approvals
        • 2024-2025
          • Trending Topics & Drug Approvals: May 2025
          • Trending Topics & Drug Approvals: June 2025
          • Trending Topics & Drug Approvals: July 2025
          • Trending Topics & Drug Approvals: August 2025
          • Trending Topics & Drug Approvals: September 2025
          • Trending Topics & Drug Approvals: November 2025
          • Trending Topics & Drug Approvals: December 2025
        • Trending Topics & Drug Approvals: January 2026
        • Trending Topics & Drug Approvals: February 2026
        • Trending Topics & Drug Approvals: March 2026
        • Trending Topics & Drug Approvals: April 2026
        • Trending Topics & Drug Approvals: May 2026
        • Trending Topics & Drug Approvals: June 2026
        • Trending Topics & Drug Approvals: July 2026
        • Trending Topics & Drug Approvals: August 2026
      • White papers
    • Stories
  • Compliance / Legal
    • California Privacy Notice and Policy
    • Disclaimer
    • Nondiscrimination + Languages
    • Notice of Privacy Practices
    • Privacy Policy
    • Subrogation
    • Terms of Use
  • Home
    • Who we are
      • About us
        • Employers
        • Health Plans
        • Consultants
        • Union
      • Our history
      • Culture
        • Diversity, equity and inclusion
          • Diverse supplier registration
      • Corporate social responsibility
        • Community giving
        • Climate reporting
        • Corporate Social Responsibility Report
        • Prime Together Foundation
      • Awards
    • Read, watch, listen
      • Read
      • Watch
      • Listen
    • Pharmacy
      • Home Delivery
        • Home Delivery - Patients
        • Home Delivery - Providers
      • Specialty Pharmacy
        • Specialty Pharmacy - Patients
          • Care Specialists Program
            • Education Center
              • Hypercholesterolemia
              • Solid organ transplant
              • Asthma
              • Cystic fibrosis
              • Hemophilia
              • Hepatitis C
              • Human Immunodeficiency Virus (HIV)
              • Inflammatory bowel disease
              • Osteoporosis
              • Multiple Sclerosis
              • Oncology (cancer)
              • Psoriasis and psoriatic arthritis
              • Rheumatoid arthritis
            • Rights and responsibilities
            • Overcome medicine challenges
        • Specialty Pharmacy - Providers
      • Patient Forms
    • Careers
      • Benefits
      • Hub + Home
      • Medication Therapy Management Internship
      • Managed Care Residency Program
      • Application Process
    • Contact Us
  • News & Insights
    • Events
    • In the news
    • Perspectives
    • Press releases
    • Research & publications
      • Cell & Gene Pipeline Outlook
        • 2024-2025
          • Cell & Gene Pipeline Outlook: November 2025
        • Cell & Gene Pipeline Outlook: January 2026
        • Cell & Gene Pipeline Outlook: June 2026
      • Clinical Insights
        • 2022 Clinical Insights: Therapeutic Psychedlics: An emerging frontier in mental health
        • 2022 Clinical Insights: Virtual reality: An emerging paradigm in healthcare
        • Summer 2025 Issue: Clinical Insights – MASH
      • Drug Approvals
        • Drug Approvals Monthly Update: January 2024
        • Drug Approvals Quarterly Update: January 2024
        • Drug Approvals Monthly Update: February 2024
        • Drug Approvals Monthly Update: April 2024
        • Drug Approvals Quarterly Update: April 2024
        • Drug Approvals Monthly Update: March 2024
        • Drug Approvals Monthly Update: May 2024
        • Drug Approvals Monthly Update: June 2024
        • Drug Approvals: July 2024
        • Drug Approvals Monthly Update: August 2024
        • Drug Approvals Monthly Update: September 2024
        • Drug Approvals: October 2024
        • Drug Approvals: November 2024
        • Drug Approvals: December 2024
        • Drug Approvals: January 2025
        • Drug Approvals: February 2025
        • Drug Approvals: March 2025
        • Drug Approvals: April 2025
      • FDA Decisions Expected
        • 2024-2025
          • FDA Decisions Expected: October 2024
          • FDA Decisions Expected November 2024
          • FDA Decisions Expected: December 2024
          • FDA Decisions Expected: January 2025
          • FDA Decisions Expected: February 2025
          • FDA Decisions Expected: March 2025
          • FDA Decisions Expected: April 2025
          • FDA Decisions Expected: May 2025
          • FDA Decisions Expected: June 2025
          • FDA Decisions Expected: July 2025
          • FDA Decisions Expected: August 2025
          • FDA Decisions Expected: September2025
          • FDA Decisions Expected: October 2025
          • FDA Decisions Expected: November 2025
          • FDA Decisions Expected: December 2025
        • FDA Decisions Expected: January 2026
        • FDA Decisions Expected: February 2026
        • FDA Decisions Expected: March 2026
        • FDA Decisions Expected: April 2026
        • FDA Decisions Expected: May 2026
        • FDA Decisions Expected: June 2026
        • FDA Decisions Expected: July 2026
        • FDA Decisions Expected: August 2026
        • FDA Decisions Expected: September 2026
        • FDA Decisions Expected: October 2026
      • GLP-1 Pipeline Update
        • 2024-2025
          • GLP-1 Pipeline Update: November 2024
          • GLP-1 Pipeline Update: November 2025
          • The evolution of GLP-1s
          • GLP-1 Pipeline Update: February 2025
          • GLP-1 Pipeline Update: May 2025
          • GLP-1 Pipeline Update: August 2025
        • GLP-1 Pipeline Update: February 2026
        • GLP-1 Pipeline Update: May 2026
        • GLP-1 Pipeline Update: August 2026
      • Medicaid Trend Report
      • Medical Pharmacy Trend Report
        • 2024 Medical Pharmacy Trend Report
        • 2025 Medical Pharmacy Trend Report
        • 2026 Medical Pharmacy Trend Report Part 1
        • 2026 Medical Pharmacy Trend Report Part 2
      • Oncology Insights
        • 2024-2025
          • Oncology Insights: Transformative treatment for small cell lung cancer
          • Oncology Insights: First-in-class bladder cancer therapy and the Bacillus Calmette-Guérin (BCG) shortage
          • Oncology Insights: October 2024
          • Oncology Insights: December 2024
          • Oncology Insights: 2024 Rewind
          • Oncology Insights: February 2025
          • Oncology Insights: March 2025
          • Oncology Insights: April 2025
          • Oncology Insights: May 2025
          • Oncology Insights: June 2025
          • Oncology Insights: July 2025
          • Oncology Insights: August 2025
          • Oncology Insights: September 2025
          • Oncology Insights: October 2025
          • Oncology Insights: November 2025
          • Oncology Insights: December 2025
        • Oncology Insights: January 2026
        • Oncology Insights: February 2026
        • Oncology Insights: March 2026
        • Oncology Insights: April 2026
        • Oncology Insights: May 2026
        • Oncology Insights: June 2026
        • Oncology Insights: July 2026
        • Oncology Insights: August 2026
      • Prime Therapeutics Report
        • Fall 2024 Prime Therapeutics Report
        • Spring 2024 Prime Therapeutics Report
        • Summer 2024 Prime Therapeutics Report
        • Spring 2025 Prime Therapeutics Report
        • Summer 2025 Prime Therapeutics Report
        • Fall 2025 Prime Therapeutics Report
        • Spring 2026 Prime Therapeutics Report
        • Summer 2026 Prime Therapeutics Report
      • Quarterly Drug Pipeline
        • 2024-2025
          • Quarterly Drug Pipeline Template 2.0
          • Quarterly Drug Pipeline: January 2024
          • Quarterly Drug Pipeline: April 2024
          • Quarterly Drug Pipeline: July 2024
          • Quarterly Drug Pipeline: October 2024
          • Quarterly Drug Pipeline: January 2025
          • Quarterly Drug Pipeline: April 2025
          • Quarterly Drug Pipeline: July 2025
          • Quarterly Drug Pipeline: October 2025
        • Quarterly Drug Pipeline: January 2026
        • Quarterly Drug Pipeline: April 2026
        • Quarterly Drug Pipeline: July 2026
      • Research posters & abstracts
      • Trending Topics & Drug Approvals
        • 2024-2025
          • Trending Topics & Drug Approvals: May 2025
          • Trending Topics & Drug Approvals: June 2025
          • Trending Topics & Drug Approvals: July 2025
          • Trending Topics & Drug Approvals: August 2025
          • Trending Topics & Drug Approvals: September 2025
          • Trending Topics & Drug Approvals: November 2025
          • Trending Topics & Drug Approvals: December 2025
        • Trending Topics & Drug Approvals: January 2026
        • Trending Topics & Drug Approvals: February 2026
        • Trending Topics & Drug Approvals: March 2026
        • Trending Topics & Drug Approvals: April 2026
        • Trending Topics & Drug Approvals: May 2026
        • Trending Topics & Drug Approvals: June 2026
        • Trending Topics & Drug Approvals: July 2026
        • Trending Topics & Drug Approvals: August 2026
      • White papers
    • Stories
  • Compliance / Legal
    • California Privacy Notice and Policy
    • Disclaimer
    • Nondiscrimination + Languages
    • Notice of Privacy Practices
    • Privacy Policy
    • Subrogation
    • Terms of Use
Login Portals
  • Members and Consumers
  • Clients and Health Plans
  • Pharmacy + Provider Resources
Compliance / Legal
  • Privacy Policy
  • Notice of Privacy Practices
  • Terms of Use
  • Nondiscrimination + Languages
  • Subrogation
Company
  • About us
  • Careers
  • News
  • Media
Contact us
© 2026 Prime Therapeutics LLC